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A BST R AC T   
 
Aim: Uric acid is the product of purine metabolism and elevated serum uric acid levels are associated 
with many metabolic conditions. In present retrospective analysis, we aimed to compare serum uric 
acid levels of well controlled type 2 diabetic subjects to those of poorly controlled type 2 DM patients. 
Methods: Medical database of type 2 diabetic subjects whom admitted to outpatient clinics of our 
institution, between January 2017 and August 2017, were retrospectively analyzed. Patients with an 
HbA1c level lower than 7, 5% were classified as well controlled and others were classified as poorly 
controlled type 2 DM group. Uric acid levels of the groups were compared. 
Results: Serum uric acid level of well controlled and poorly controlled diabetics were 4.1 (2, 8-5, 9) 
mg/dl and 5, 9 (4-9, 6) mg/dl, respectively. The difference was statistically significant (p<0.001). A 
Pearson’s correlation test was revealed that serum uric acid was strongly and positively correlated 
with HbA1c (r=0.81, p<0.001).  
Conclusion: Serum uric acid levels worsen in poorly controlled type 2 diabetic subjects. Since HbA1c 
levels reflects changes in 3 months period, variations in serum uric acid levels could be used as a 
predictor of diabetic control level in shorter time periods. 
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Introduction 
As a product of purine metabolism, uric acid, 
produced by the activation of xanthine oxidase 
enzyme. Increased uric acid, namely, 
hyperuricemia, is associated with hypertension 
[1], in oxidative stress [2], vascular smooth 
muscle cell proliferation [3] and activation of 
white blood cells [4].  
Occurrence rate of metabolic syndrome in type 
2 diabetes mellitus (DM) is increased as serum 
uric levels elevated [5]. Moreover, 
hyperuricemia was found to be associated with 
development of chronic kidney disease in 
subjects with type 2 DM [6].  
In present retrospective analysis, we aimed to 
compare serum uric acid levels of well 
controlled type 2 diabetic subjects to those of 
poorly controlled type 2 DM patients. 
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Medical database of type 2 diabetic subjects 
whom admitted to outpatient clinics of our 
institution between January 2017 and August 
in 2017 were retrospectively analyzed. 
Medical and laboratory data obtained from 
computerized database and patient file system 
and recorded. Patients with an HbA1c level 
lower than 7, 5% were classified as well 
controlled and others were classified as poorly 
controlled type 2 DM group.  
Exclusion criteria were as follows: age 
younger than 18, active inflammation or 
infection, malignancy and pregnancy for 
women. Age, gender, height, weight, and waist 
circumference of the participants were 
obtained from computerized database and 
recorded.  
A body mass index (BMI) was calculated by 
dividing of the weight in kilograms to the 
square of height in meters. Duration of DM 
was also recorded. 
Serum urea, creatinine, fasting plasma glucose, 
uric acid, HDL cholesterol and triglyceride 
were obtained from the same database and 
recorded.  
Data were analyzed by SPSS software. (SPSS 
15.0; IBM Inc., Chicago, IL, USA). 
Kolmogorov-Smirnov test conducted to 
observe distribution of variables in study 
groups. Homogenous variables were expressed 
as mean ± standard deviation and compared by 
independent samples t test, whereas, non-
homogenous variables were expressed as  
median (minimum – maximum) and compared 
by  Mann-Whitney U test. Comparison of 
categorical variables in study groups was 
conducted with Chi-square test. Correlation 
between studies parameters was done with 
Pearson’s correlation analyze test. A p value of 
< 0.05 is considered as statistically significant. 
 
Results 
Study population was consisted of 136 
subjects; 61 well controlled and 75 poorly 
diabetics. The patients with well-controlled 
type 2 DM (61 ±12 years) were significantly 
older than poorly-controlled subjects (56 ± 10 
years), (p=0.02). 36 of 61 in well-controlled 
type 2 DM group and 34 of 71 in poorly 
controlled group were women. Gender was not 
statistically different between study groups 
(p=0.11).  
Despite well-controlled subjects were shorter 
(160cm [145-181]) than poorly controlled 
(165cm [146-178]) diabetics (p=0.046), 
weight (p=0.21), waist circumference (p=0.91) 
and body mass index (p=0.79) were not 
statistically different between study groups.   
As expected, fasting plasma glucose of well-
controlled type 2 diabetic patients (131±26 
mg/dl) was significantly lower than poorly 
controlled subjects (225±19 mg/dl), (p<0.001). 
Similarly, HbA1c of well-controlled type 2 
diabetic patients (6,8% [5,1-7,4]) was 
significantly lower than poorly controlled 
diabetics (9,3% [7,6-16,5]), (p<0.001). 
Systolic (p=0.74) and diastolic (p=0.34) blood 
pressures were similar in well-controlled and 
poorly controlled diabetics. Serum triglyceride 
of well-controlled group (152±55mg/dl) was 
significantly lower than poorly controlled 
group (221 ±74 mg/dl), (p=0.003). On the 
other hand, serum HDL cholesterol levels of 
the well-controlled and poorly controlled 
subjects were not different (p=0.51).  
Duration of diabetes mellitus (3 years [1-20] in 
well-controlled vs 5 years [1-24] in poorly 
controlled group), blood urea (30 mg/dl [13-
58] in well-controlled vs 32 mg/dl [17-58] in 
poorly controlled group), and creatinine (0,77 
mg/dl [0,66-1,5] in well-controlled vs 0,84 
mg/dl [0,5-1,87] in poorly controlled group) 
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was not statistically different between study 
groups (p>0.005 for all).  
Serum uric acid level of well controlled and 
poorly controlled diabetics were 4.1 (2,8-5,9) 
mg/dl and 5,9 (4-9,6) mg/dl, respectively. The 
difference was statistically significant 
(p<0.001).  
A Pearson’s correlation test was revealed that 
serum uric acid was strongly and positively 
correlated with HbA1c (r=0.81, p<0.001).  
 
Discussion 
We showed in present retrospective study that 
serum uric acid levels are increased in poorly 
controlled type 2 DM patients compared to 
well-controlled type 2 diabetic subjects. 
Positive and strong correlation between uric 
acid and HbA1c is another important finding 
of our report.  
Elevated serum uric acid level is a common 
feature in type 2 DM. Association between 
arterial stiffness and serum uric acid in male 
type 2 diabetic subjects in a study from China 
[7]. Another study pointed that increase in 
serum uric acid was related with worsening of 
diabetic retinopathy [8]. Similarly, increased 
uric acid may contribute to diabetic 
nephropathy. Hyperuricemia induces 
macrophages in renal tissue and promotes and 
progression of diabetic nephropathy in subjects 
with type 2 DM [9]. Both of these macro-
vascular and micro-vascular complications of 
type 2 DM are associated with worse HbA1c 
levels. Thus, correlation between uric acid and 
HbA1c is not surprising.  
Uric acid secretion from adipose tissue in 
obese is increased [10]. Authors found that uric 
acid levels of non-diabetic obese are higher 
than non-diabetic overweight subjects [11]. A 
report from China studied the association 
between serum uric acid and obesity in 
university students and found a positive 
correlation between body mass index and uric 
acid [12]. Although obesity and serum uric 
acid levels seem to be associated in non-
diabetic population, there was no relation 
between uric acid and body mass index, weight 
or waist circumference in our study.    
Xue et al. compared serum uric acid levels of 
pre-diabetic patients and subjects with normal 
glucose tolerance and reported higher uric acid 
in pre-diabetic subjects [13].  
In contrast to present report, Cui et al found 
that serum uric acid was negatively correlated 
with HbA1c levels [14]. However, authors 
concluded that such negative association was a 
result of hyperinsulinemia in type 2 DM 
patients. In a study from Iran, reported that pre-
diabetic persons have higher serum uric acid 
levels compared to subjects with normal 
glucose tolerance [15]. However, subjects with 
pre-diabetes were older and more obese than 
normal persons in their study. Therefore, our 
results by comparison of uric acid levels in 
BMI identic groups were more valuable.  
Limitations of present study are relatively 
small study population and retrospective 
design, which could make our results 
controversial. However, strong and positive 
correlation between HbA1c and serum uric 
acid levels is an important finding which may 
add a lot to current literature.  
In conclusion, serum uric acid levels worsen in 
poorly controlled type 2 diabetic subjects. 
Since HbA1c levels reflects changes in 3 
months period, variations in serum uric acid 
levels could be used as a predictor of diabetic 
control level in shorter time periods.  
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